Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Preliminary Evaluation of the Amyloid Binding Properties, Pharmacokinetics and Safety of 18F-AV-45 in Healthy Elderly Volunteers and Patients With Alzheimer's Disease

NCT01565291 is registered in ClinicalTrials.gov with Avid Radiopharmaceuticals as lead sponsor.

NCT NCT01565291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01565291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Preliminary Evaluation of the Amyloid Binding Properties, Pharmacokinetics and Safety of 18F-AV-45 in Healthy Elderly Volunteers and Patients With Alzheimer's Disease
Lead sponsor
Avid Radiopharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2007
Completion date
January 31, 2008
Enrollment
32 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease